Literature DB >> 15220452

Comparison of herpes simplex virus reactivation in ganglia in vivo and in explants demonstrates quantitative and qualitative differences.

N M Sawtell1, R L Thompson.   

Abstract

The in vivo ganglionic environment directs the latent herpes simplex virus transcriptional program. Since stress-driven perturbations in sensory neurons are thought to play a critical role in the transition from latency to reactivation, a primary concern in the selection of a valid model of the molecular interactions leading to reactivation is the faithful recapitulation of these environments. In this study reactivation of latently infected ganglia excised and cultured in vitro (explanted) is compared to reactivation occurring in latently infected ganglia in vivo following hyperthermic stress. Three notable points emerged. (i). Neurons in explanted ganglia exhibited marked morphological changes within 2 to 3 h postexplant. DNA fragmentation in neuronal nuclei was detected at 3 h, and atypical expression of cell cycle- and stress-regulated proteins such as geminin, cdk2, cdk4, and cytochrome c became apparent at 2 to 48 h. These changes were associated with axotomy and explant and not with the initiation or progression of reactivation and were not observed in ganglia following in vivo hyperthermic stress. (ii). Despite these differences, during the first 22 h primary reactivation events were restricted to a very small number of neurons in vivo and in explanted ganglia. This suggests that at any given time only a few latently infected neurons are competent to reactivate or that the probability of reactivation occurring in any particular neuron is very low. Importantly, the marked changes detected in explanted ganglia were not correlated with increased reactivation, demonstrating that these changes were not associated with the reactivation process per se. (iii). Secondary spread of virus was evident in explanted ganglia within 36 h, an event not observed in vivo. We conclude that explant reactivation may provide an ancillary system for selected studies of the early events in reactivation. However, clear signs of neuronal degeneration within 2 to 3 h postexplant indicate that these ganglia are undergoing major physiological changes not associated with the reactivation process. This ongoing neurodegeneration could alter even the early virus-host interactions in reactivation, and thus caution in the extrapolation of results obtained in explants to the in vivo interactions initiating reactivation is warranted.

Entities:  

Mesh:

Year:  2004        PMID: 15220452      PMCID: PMC434126          DOI: 10.1128/JVI.78.14.7784-7794.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Explant-induced reactivation of herpes simplex virus occurs in neurons expressing nuclear cdk2 and cdk4.

Authors:  Luis M Schang; Andrew Bantly; Priscilla A Schaffer
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

2.  Quantitative analysis of herpes simplex virus reactivation in vivo demonstrates that reactivation in the nervous system is not inhibited at early times postinoculation.

Authors:  N M Sawtell
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

3.  Specific inhibitors of herpes simplex virus thymidine kinase diminish reactivation of latent virus from explanted murine ganglia.

Authors:  D A Leib; K L Ruffner; C Hildebrand; P A Schaffer; G E Wright; D M Coen
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

4.  Replication of herpes simplex virus type 1 within trigeminal ganglia is required for high frequency but not high viral genome copy number latency.

Authors:  R L Thompson; N M Sawtell
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  Herpes simplex virus type 1 latency-associated transcript gene promotes neuronal survival.

Authors:  R L Thompson; N M Sawtell
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

6.  A temporal analysis of acyclovir inhibition of induced herpes simplex virus type 1 In vivo reactivation in the mouse trigeminal ganglia.

Authors:  N M Sawtell; D I Bernstein; L R Stanberry
Journal:  J Infect Dis       Date:  1999-09       Impact factor: 5.226

7.  Cell cycle. License withheld--geminin blocks DNA replication.

Authors:  Z Lygerou; P Nurse
Journal:  Science       Date:  2000-12-22       Impact factor: 47.728

8.  Inhibition of eukaryotic DNA replication by geminin binding to Cdt1.

Authors:  J A Wohlschlegel; B T Dwyer; S K Dhar; C Cvetic; J C Walter; A Dutta
Journal:  Science       Date:  2000-12-22       Impact factor: 47.728

9.  An improved model of recurrent herpetic eye disease in mice.

Authors:  C Shimeld; T Hill; B Blyth; D Easty
Journal:  Curr Eye Res       Date:  1989-11       Impact factor: 2.424

10.  Transcription at early stages of herpes simplex virus 1 infection and during reactivation.

Authors:  Ingeborg Rezuchová; Marcela Kúdelová; Vladmíra Durmanová; Andrea Vojvodová; Ján Kosovský; Július Rajcáni
Journal:  Intervirology       Date:  2003       Impact factor: 1.763

View more
  43 in total

1.  Therapeutic implications of new insights into the critical role of VP16 in initiating the earliest stages of HSV reactivation from latency.

Authors:  Richard L Thompson; Nancy M Sawtell
Journal:  Future Med Chem       Date:  2010-07       Impact factor: 3.808

2.  Reactivation from quiescence does not coincide with a global induction of herpes simplex virus type 1 transactivators.

Authors:  Robert J Danaher; Robert J Jacob; Craig S Miller
Journal:  Virus Genes       Date:  2006-10       Impact factor: 2.332

3.  Evidence that the herpes simplex virus type 1 ICP0 protein does not initiate reactivation from latency in vivo.

Authors:  R L Thompson; N M Sawtell
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

4.  Herpes simplex virus 1 immediate-early and early gene expression during reactivation from latency under conditions that prevent infectious virus production.

Authors:  Jean M Pesola; Jia Zhu; David M Knipe; Donald M Coen
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  Herpes simplex virus DNA synthesis is not a decisive regulatory event in the initiation of lytic viral protein expression in neurons in vivo during primary infection or reactivation from latency.

Authors:  N M Sawtell; R L Thompson; R L Haas
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

6.  Herpes Simplex Virus 1 Replication, Ocular Disease, and Reactivations from Latency Are Restricted Unilaterally after Inoculation of Virus into the Lip.

Authors:  Nolwenn Poccardi; Antoine Rousseau; Oscar Haigh; Julie Takissian; Thierry Naas; Claire Deback; Louise Trouillaud; Mohammad Issa; Simon Roubille; Franceline Juillard; Stacey Efstathiou; Patrick Lomonte; Marc Labetoulle
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

Review 7.  Latent versus productive infection: the alpha herpesvirus switch.

Authors:  Orkide O Koyuncu; Margaret A MacGibeny; Lynn W Enquist
Journal:  Future Virol       Date:  2018-05-22       Impact factor: 1.831

8.  Neuronal Stress Pathway Mediating a Histone Methyl/Phospho Switch Is Required for Herpes Simplex Virus Reactivation.

Authors:  Anna R Cliffe; Jesse H Arbuckle; Jodi L Vogel; Matthew J Geden; Scott B Rothbart; Corey L Cusack; Brian D Strahl; Thomas M Kristie; Mohanish Deshmukh
Journal:  Cell Host Microbe       Date:  2015-12-09       Impact factor: 21.023

9.  Thyroid hormone controls the gene expression of HSV-1 LAT and ICP0 in neuronal cells.

Authors:  Gautam R Bedadala; Rajeswara C Pinnoji; Jayavardhana R Palem; Shao-Chung V Hsia
Journal:  Cell Res       Date:  2010-04-13       Impact factor: 25.617

10.  Early CD4(+) T cell help prevents partial CD8(+) T cell exhaustion and promotes maintenance of Herpes Simplex Virus 1 latency.

Authors:  Gregory M Frank; Andrew J Lepisto; Michael L Freeman; Brian S Sheridan; Thomas L Cherpes; Robert L Hendricks
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.